Clearside Biomedical (CLSD) Downgraded by Zacks Investment Research to Hold

Clearside Biomedical} stock has undergone multiple analysts rating changes in the recent past.  Clearside Biomedical Downgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Clearside Biomedical (CLSD) Downgraded by Zacks Investment Research to Hold

Clearside Biomedical (NASDAQ:CLSD) Upgraded by Zacks Investment Research to Buy

Clearside Biomedical} stock has undergone multiple analysts rating changes in the recent past.  Clearside Biomedical Upgraded by Zacks Investment Research on 10/12/2021. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

View More Clearside Biomedical (NASDAQ:CLSD) Upgraded by Zacks Investment Research to Buy